Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 2
2017 2
2018 3
2019 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
O-GlcNAc transferase suppresses necroptosis and liver fibrosis.
Zhang B, Li MD, Yin R, Liu Y, Yang Y, Mitchell-Richards KA, Nam JH, Li R, Wang L, Iwakiri Y, Chung D, Robert ME, Ehrlich BE, Bennett AM, Yu J, Nathanson MH, Yang X. Zhang B, et al. Among authors: mitchell richards ka. JCI Insight. 2019 Nov 1;4(21):e127709. doi: 10.1172/jci.insight.127709. JCI Insight. 2019. PMID: 31672932 Free PMC article.
Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma.
Torgersen J, Taddei TH, Park LS, Carbonari DM, Kallan MJ, Mitchell Richards K, Zhang X, Jhala D, Bräu N, Homer R, D'Addeo K, Mehta R, Skanderson M, Kidwai-Khan F, Justice AC, Lo Re V 3rd. Torgersen J, et al. Among authors: mitchell richards k. Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):71-78. doi: 10.1158/1055-9965.EPI-19-0503. Epub 2019 Oct 1. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31575557 Free PMC article.
Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH.
Wang J, Cho NL, Zauber AG, Hsu M, Dawson D, Srivastava A, Mitchell-Richards KA, Markowitz SD, Bertagnolli MM. Wang J, et al. Among authors: mitchell richards ka. Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):728-736. doi: 10.1158/1055-9965.EPI-17-0573. Epub 2018 May 16. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29769213 Free PMC article.
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE; Alliance for Clinical Trials in Oncology. Edelman MJ, et al. Among authors: mitchell richards k. J Clin Oncol. 2017 Jul 1;35(19):2184-2192. doi: 10.1200/JCO.2016.71.3743. Epub 2017 May 10. J Clin Oncol. 2017. PMID: 28489511 Free PMC article. Clinical Trial.
Nuclear Factor, Erythroid 2-Like 2 Regulates Expression of Type 3 Inositol 1,4,5-Trisphosphate Receptor and Calcium Signaling in Cholangiocytes.
Weerachayaphorn J, Amaya MJ, Spirli C, Chansela P, Mitchell-Richards KA, Ananthanarayanan M, Nathanson MH. Weerachayaphorn J, et al. Among authors: mitchell richards ka. Gastroenterology. 2015 Jul;149(1):211-222.e10. doi: 10.1053/j.gastro.2015.03.014. Epub 2015 Mar 18. Gastroenterology. 2015. PMID: 25796361 Free PMC article.